Showing results (241-250 of 254) with videos related to
Sort By:
Pageof 26
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2011
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaChristopher A Hewson, Sheena Patel, Luigino Calzetta, et al.Scientific Data|May 16, 2015
Long-read, whole-genome shotgun sequence data for five model organismsKristi E Kim, Paul Peluso, Primo Babayan, et al.Bioorganic & Medicinal Chemistry Letters|June 9, 2009
SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic dataSimon J Mantell, Peter T Stephenson, Sandra M Monaghan, et al.Leukemia|November 26, 2011
The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemiaC E de Bock, A Ardjmand, T J Molloy, et al.Bioorganic & Medicinal Chemistry Letters|September 2, 2011
Design and synthesis of long acting inhaled corticosteroids for the treatment of asthmaDavid S Millan, Stephen A Ballard, Sara Chunn, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2014
Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United StatesMinal Kapoor, Kimberly Pringle, Alan Kumar, et al.Journal of Medicinal Chemistry|September 1, 2010
Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroupPaul A Glossop, Charlotte A L Lane, David A Price, et al.Journal of Medicinal Chemistry|September 6, 2011
Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary diseaseDavid S Millan, Mark E Bunnage, Jane L Burrows, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary diseaseSimon J Mantell, Peter T Stephenson, Sandra M Monaghan, et al.Leukemia & Lymphoma|September 25, 2014
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemiaSimon Z He, Samantha Busfield, David S Ritchie, et al.Pageof 26